Prostate Cancer Screening in Fort Worth, TX at DFWPMA

Looking for prostate cancer screening in Fort Worth? At DFW Physicians Medical Associates (DFWPMA), our family medicine and internal medicine physicians provide men’s preventive healthcare, including prostate cancer risk assessments and consultations about prostate-specific antigen (PSA) testing to help patients make informed screening decisions.

Prostate cancer screening commonly involves a PSA blood test, which measures prostate-specific antigen levels to identify possible prostate abnormalities before symptoms develop. An elevated PSA result does not necessarily indicate cancer, and additional evaluation may be necessary to determine its cause.

Whether you’re considering your first PSA test, reviewing previous screening results, or concerned about a family history of prostate cancer, DFWPMA offers individualized primary care evaluations to help determine whether screening is appropriate based on your age, medical history, risk factors, and preferences.

Book an appointment online or call (903) 957-0082 to contact our Fort Worth scheduling team.

Address: 📍 1220 W. Presidio St., Fort Worth, TX 76102
Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for Prostate Cancer Screening in Fort Worth?

DFW Physicians Medical Associates provides preventive men’s healthcare in Fort Worth through family medicine and internal medicine physicians experienced in adult primary care, men’s health, preventive screenings, chronic disease management, and individualized medical evaluations.

Patients considering prostate cancer screening at DFWPMA can benefit from:

  • Experienced Primary Care Physicians: Access to Dr. Michael Huang, Dr. Anisha Zaman, and Dr. Soheila Hesami, whose clinical backgrounds include men’s health, preventive medicine, and comprehensive adult healthcare.
  • Individualized Prostate Cancer Risk Assessment: Evaluation of age, family history, previous PSA results, and personal health factors to determine whether screening discussions are appropriate.
  • Preventive Men’s Healthcare: Comprehensive medical assessments that consider prostate health, chronic medical conditions, and other recommended preventive services.
  • PSA Screening Guidance: Education about prostate-specific antigen testing, its potential benefits, limitations, and possible consequences of abnormal findings.
  • Abnormal PSA Result Evaluation: Medical review of elevated PSA levels and guidance regarding repeat testing, additional evaluation, or urology referrals when appropriate.
  • Shared Medical Decision-Making: Clear discussions about screening recommendations, individual preferences, potential false-positive results, and the risks of unnecessary testing.
  • Coordinated Men’s Healthcare: Access to primary care evaluations and specialist referrals when additional prostate assessment or diagnostic testing is clinically indicated.

Prostate cancer screening requires careful consideration because PSA testing may identify clinically significant cancer but can also detect abnormalities that would never cause symptoms. The decision to screen should reflect individual risk, potential benefits and harms, and informed patient preferences rather than automatic annual testing.

Schedule an appointment with DFWPMA Fort Worth to discuss prostate cancer screening and your preventive men’s healthcare needs.

Meet Our Prostate Cancer Screening Providers in Fort Worth

Dr. Michael Huang, MD

Dr. Michael Huang is a board-certified family medicine physician with more than 13 years of experience providing comprehensive healthcare, including men’s health, preventive screenings, annual physicals, and chronic disease management. He earned his medical degree from the American University of the Caribbean School of Medicine and completed his Family Medicine Residency at UT Southwestern Medical Center.

Dr. Huang’s background in men’s preventive healthcare supports prostate cancer risk assessments, PSA screening discussions, and evaluation of prostate-related concerns. Fluent in English and Spanish, he emphasizes personalized medical care, helping patients understand their screening options and make informed healthcare decisions.

Dr. Anisha Zaman, MD

Dr. Anisha Zaman is a family medicine physician experienced in comprehensive outpatient care, men’s health, preventive medicine, and primary care procedures. She earned her medical degree from Ross University School of Medicine and completed her Family Medicine Residency at the University of Arkansas for Medical Sciences (UAMS) North Central.

Her clinical background supports prostate cancer risk evaluations, preventive men’s healthcare, and patient education regarding PSA testing. Dr. Zaman emphasizes individualized care, helping patients understand their medical risk factors, discuss recommended screenings, and make informed decisions about their long-term health.

Dr. Soheila Hesami, MD

Dr. Soheila Hesami is a board-certified internal medicine physician with more than 20 years of clinical experience providing comprehensive adult healthcare. Her expertise includes preventive medicine, annual health screenings, chronic disease management, and individualized medical evaluations for adults and older patients.

Dr. Hesami’s extensive experience in adult preventive care is relevant to prostate cancer risk assessments and discussions about PSA screening. She emphasizes evidence-based medicine, careful evaluation of each patient’s health history, and collaborative decisions that consider individual medical needs and screening preferences.

Book an appointment online to inquire about prostate cancer screening evaluations and preventive men’s healthcare with our Fort Worth primary care physicians.

What Can Prostate Cancer Screening in Fort Worth Help With?

Prostate cancer screening helps identify men who may require further evaluation for prostate cancer before symptoms develop. PSA testing measures a protein produced by prostate tissue, but an elevated result cannot independently diagnose cancer. Screening decisions must consider the possibility of early detection alongside false-positive results, overdiagnosis, and unnecessary treatment.

At DFWPMA Fort Worth, prostate cancer screening evaluations and related preventive care may help with:

  • Prostate Cancer Risk Assessment: Identifying personal and family history factors that may increase the likelihood of developing prostate cancer.
  • PSA Screening Evaluation: Determining whether prostate-specific antigen blood testing is appropriate after discussing potential benefits and harms.
  • Elevated PSA Level Assessment: Reviewing abnormal results that may be associated with prostate cancer, benign prostate enlargement, or prostate inflammation.
  • Routine Men’s Preventive Care: Incorporating prostate cancer risk discussions into age-appropriate primary care evaluations and preventive health visits.
  • Abnormal Screening Follow-Up: Evaluating previous PSA findings to determine whether repeat testing, additional assessment, or urology consultation is appropriate.
  • Individualized Screening Decisions: Considering age, family history, overall health, life expectancy, and patient preferences when discussing prostate cancer screening.

According to the U.S. Preventive Services Task Force (USPSTF), its current final recommendation supports individualized decisions about PSA-based prostate cancer screening for men ages 55–69 after discussing potential benefits and harms with a clinician. The USPSTF recommends against routine PSA-based screening for men ages 70 and older.

These recommendations apply to men without prostate cancer symptoms or a previous prostate cancer diagnosis. Men with a family history of prostate cancer or other elevated risk factors may benefit from earlier discussions about screening, although evidence supporting routine PSA testing before age 55 remains limited under the USPSTF recommendation.

A PSA blood test cannot confirm prostate cancer. Elevated levels may result from benign prostatic hyperplasia, prostatitis, or other noncancerous conditions. Men experiencing urinary difficulties, blood in the urine, or other concerning symptoms require diagnostic evaluation rather than relying solely on routine screening.

What Prostate Cancer Screening Services Are Available in Fort Worth?

Prostate cancer screening services generally involve assessing individual cancer risk, discussing PSA blood testing, interpreting screening results, and determining whether additional evaluation is necessary. The appropriate approach depends on age, family history, previous PSA measurements, overall health, and informed patient preferences.

At DFWPMA Fort Worth, men’s preventive healthcare and prostate screening evaluations may include:

  • PSA Blood Testing Consultation: Assessment of whether prostate-specific antigen testing is appropriate, with testing arrangements determined by clinical recommendations and service availability.
  • Prostate Cancer Risk Assessment: Review of age, family history, previous screening results, and medical factors influencing prostate cancer risk.
  • Screening Benefits and Risks Discussion: Explanation of possible early detection benefits, false-positive results, overdiagnosis, and potential consequences of additional procedures.
  • Abnormal PSA Result Evaluation: Review of elevated or changing PSA measurements to determine whether repeat testing or specialist assessment is appropriate.
  • Preventive Men’s Health Visits: Comprehensive primary care evaluations addressing prostate health concerns, cardiovascular risk, chronic conditions, and other preventive healthcare needs.
  • Urology Referrals: Coordination of specialist evaluation when abnormal findings warrant additional testing, prostate imaging, or consideration of biopsy.
  • Screening Follow-Up and Education: Guidance regarding PSA results, appropriate reassessment intervals, individual risk factors, and recommended next steps.

During PSA screening, a healthcare professional collects a blood sample to measure prostate-specific antigen levels. The test itself requires only a routine blood draw. A digital rectal examination may be considered selectively as part of a clinical assessment but is not recommended as a stand-alone prostate cancer screening test.

An elevated PSA result does not automatically mean prostate cancer. According to the American Academy of Family Physicians (AAFP), abnormal PSA measurements should generally be repeated within a few months before proceeding to additional biomarkers, urology referral, biopsy, or imaging, depending on clinical circumstances.

Prostate cancer screening should be guided by evidence-based recommendations and individual medical history. Unnecessary testing may lead to false-positive results, avoidable biopsies, and treatment-related complications, while appropriate evaluation can help identify potentially significant prostate cancer in selected patients.

Looking for prostate cancer screening in Fort Worth? Contact DFWPMA to schedule a preventive men’s healthcare appointment, discuss PSA testing availability, and review your individual prostate cancer screening options.